Book a free consultation
A no-obligation conversation with our care team, arranged through KPCIRC.
Book a consultationPlatform · accountability, safety and data
Governance
Our technology may analyse, match and model, but it never diagnoses, prescribes, or has the final word.
01Accountability, safety and data
The founding principle
Software informs. Humans decide.
Our technology may analyse, match and model, but it never diagnoses, prescribes, or has the final word. Every clinically consequential decision is authored and signed by a licensed clinician. This principle shapes how we build, validate and deploy everything.
02
Clinical accountability and regulatory posture
Clinical authority sits with KPCIRC’s molecular tumour board: licensed clinicians who review and sign every report, who can be consulted directly, and who provide second opinions and genetic counselling. There is always a named, accountable human behind an OnKommon decision.
The molecular assays are performed to accredited laboratory standards. Our registration of the genomic tests as IVD medical devices with CDSCO is in progress, with the class pending. The interpretation engine is provided for research and decision-support use, not autonomous diagnosis. We do not overstate regulatory status. Where something is investigational, we say so.
03
Data protection
Consent first
Testing and any research use require explicit, informed consent.
DPDPA 2023
Personal and health data handled under India’s data protection act.
Security
Encryption, access control and audit trails throughout.
Purpose limitation
Data is used for your care, and for research only with separate consent.
04
Limits we are transparent about
- Liquid-biopsy sensitivity. A “not detected” result depends on tumour DNA shedding and cannot rule out disease.
- Variants of uncertain significance. Not every finding has a clear meaning yet, and we say when evidence is emerging.
- Sampling. Tissue reflects the sampled region, and tumours can be heterogeneous.
- Not an emergency service. In an emergency, contact your nearest hospital.
05
Quality
Sequencing and variant calling are performed by a CAP-accredited, ISO 15189 laboratory partner following ACMG/AMP/ASCO/CAP guidelines and a CE-IVD certified variant database. Interpretation runs against a versioned knowledge base, so every report is reproducible and states the exact version that produced it.
Take the next step
Three ways forward. Pick the one that fits today.
Begin Blueprint Care
Commission your decision report and a dedicated clinical team.
Explore Blueprint CareAsk on WhatsApp, free
Signal replies to your first question within four hours, at no cost.
Start with Signal